Major Neuronetics (NASDAQ: STIM) holder adds 169K shares

Rhea-AI Filing Summary

Neuronetics, Inc. insider activity: 10% owner Jorey Chernett purchased 169,472 shares of Neuronetics common stock in an open-market transaction at a weighted average price of $1.41 per share. The footnote states the trades occurred in multiple transactions between $1.36 and $1.44 per share, rounded to the nearest cent.

Following this purchase, Chernett directly holds 8,743,276 Neuronetics shares. The filing notes he can provide detailed breakdowns of the number of shares bought at each specific price upon request by the company, its security holders, or the SEC staff.

Insider Trade Summary

Net Buyer: 169,472 shares ($238,956)

Net Buy 1 txn

Insider Chernett Jorey

Role 10% Owner

Bought 169,472 shs ($239K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	169,472	$1.41	$239K

Holdings After Transaction: Common Stock — 8,743,276 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		P		169,472	A	$1.41(1)	8,743,276	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.36 to $1.44, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

	/s/ Jorey Chernett	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Neuronetics (STIM) report in this Form 4?

Neuronetics reported an open-market purchase by a major shareholder. Ten percent owner Jorey Chernett bought 169,472 shares of Neuronetics common stock, increasing his direct holdings and documenting the transaction details, including pricing and total post-transaction ownership, in the Form 4 filing with the SEC.

How many Neuronetics (STIM) shares did the 10% owner buy and at what price?

The 10% owner purchased 169,472 Neuronetics shares. These common shares were acquired in open-market trades at a weighted average price of $1.41 per share, with individual trades executed within a reported price range from $1.36 to $1.44, rounded to the nearest cent.

What is the new shareholding of the reporting person in Neuronetics (STIM)?

After the transaction, the reporting person holds 8,743,276 shares. The Form 4 states that, following the open-market purchase of 169,472 shares, 10% owner Jorey Chernett’s direct ownership in Neuronetics common stock increased to a total of 8,743,276 shares.

Was the Neuronetics (STIM) insider transaction an open-market purchase?

Yes, the transaction was an open-market purchase of common stock. The Form 4 classifies the trade with code “P” and describes it as an open-market or private transaction purchase, confirming that the 169,472 Neuronetics shares were acquired through market transactions rather than as a grant or derivative exercise.

What price range did the Neuronetics (STIM) insider pay for the shares?

The insider paid between $1.36 and $1.44 per share. According to the footnote, the 169,472 shares were bought in multiple trades within this range, with the reported $1.41 figure representing a weighted average purchase price rounded to the nearest cent across all transactions.

Does the Neuronetics (STIM) Form 4 mention derivative securities or options?

No derivative securities are listed in this Form 4 excerpt. The reported transaction involves only Neuronetics common stock as a non-derivative security, and the derivative summary section shows no remaining derivative positions or option exercises associated with this specific insider filing.